Enzolytics Inc (ENZC)

[God_Father]

I am going to give everyone a free piece of advice and will provide some general knowledge you should all be equipped with.

Advice: When investing in a company, it is GOOD to have an understanding of how the share structure changes overtime and more importantly, in what context. I typically do this by taking snapshots on my phone and reviewing it at a later date. I did this with ENZC, I took a snapshot sometime ago where September 30th data was published, and then most recently with the share structure update.

Here is what I found. The Outstanding shares increased by 320MM shares over the course of 42 days.

Of these 320MM shares diluted, 120MM shares are restricted and NOT tradeable. We would have only felt a maximum unrestricted of 200MM shares. While the stock is unrestricted, it means someone(s) is holding this share, but it does NOT mean it is being sold in the market. We don't have the new float number for November, but we know this: the float does NOT need to increase as the unrestricted shares increase. For all we know, NONE of these shares have hit the market and there would be no dilution effect--this could all be retail. Additionally, we know that the float could not have increased by more than 200MM shares as this was how much the unrestricted shares increased by.

I don't know what time frame you are calling the 750MM share increase, but I can clearly see from the information that this was not physically possible between September 30th and November 9th. Only 200MM shares have been diluted into the float. The remaining 120MM is likely part of the ENZC/BIOCLONETIC deal where Charles can own shares in the company. For all we know, all of the 320MM shares have been given to Charles and other officers in the company, and NOT a single share has been sold in the market.

Context:
On November 10th, the Company issued a PR and stated this "As part of the initial $500,000.00 funding, the Company and certain of its current convertible debt holders have agree to a 30-day standstill on issuance of any additional shares from conversions of debt." While I don't doubt that some shares have been converted in recent history, dilution has significantly subsided due to the 30 day convertible stand-still. The company is outright telling us they are planning to payoff the debt with CASH to debt holders to cease future dilution. Again, Bioclonetics inherited the good and the bad from ENZC. They are in the process of cleaning this all up now. Keep your eyes on the prize.

Additionally, I checked the Share Structure over the previous 4 days, and there has been ZERO dilution.

Summary:
To everyone, do your part in due diligence and spend more time analyzing data rather than posting on iHub